Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Julphar
Daiichi Sankyo
Fish and Richardson
Harvard Business School
Deloitte
Citi
Moodys

Generated: November 19, 2018

DrugPatentWatch Database Preview

Hi Tech Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for HI TECH PHARMA, and what generic and branded alternatives to HI TECH PHARMA drugs are available?

HI TECH PHARMA has forty-nine approved drugs.



Summary for Hi Tech Pharma
US Patents:0
Tradenames:43
Ingredients:40
NDAs:49

Drugs and US Patents for Hi Tech Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hi Tech Pharma GABAPENTIN gabapentin SOLUTION;ORAL 078974-001 Feb 18, 2011 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hi Tech Pharma OFLOXACIN ofloxacin SOLUTION/DROPS;OTIC 076616-001 Mar 17, 2008 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hi Tech Pharma EMBELINE E clobetasol propionate CREAM;TOPICAL 075325-001 Dec 24, 1998 AB2 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hi Tech Pharma HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 040613-001 Feb 8, 2008 AA RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Hi Tech Pharma HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride SYRUP;ORAL 040010-001 Oct 28, 1994 AA RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
UBS
AstraZeneca
Fuji
Covington
Chinese Patent Office
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.